Pectins and pectic-oligosaccharides inhibit Escherichia coli O157:H7 Shiga toxin as directed towards the human colonic cell line HT29

FEMS Microbiol Lett. 2003 Jan 21;218(1):101-5. doi: 10.1111/j.1574-6968.2003.tb11504.x.

Abstract

Pectins and pectic-oligosaccharides, as derived by controlled enzymatic hydrolysis, were evaluated for their ability to interfere with the toxicity of Shiga-like toxins from Escherichia coli O157:H7. Both types of material resulted in some degree of protection but this was significantly higher (P>0.01) with the oligosaccharide fractions (giving 90-100% cell survival, compared to 70-80% with the polymer). An effect of methylation on the protective effect was detected with lower degrees being more active. The pectic-oligosaccharides and galabiose, the minimum toxin receptor analogue, were shown to inhibit toxicity and were both protective at 10 mg x ml(-1), but not at lower concentrations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Escherichia coli Infections / drug therapy*
  • Escherichia coli O157 / pathogenicity*
  • HT29 Cells
  • Humans
  • Oligosaccharides / pharmacology*
  • Pectins / pharmacology*
  • Shiga Toxin 2 / antagonists & inhibitors*
  • Shiga Toxin 2 / toxicity
  • Virulence

Substances

  • Oligosaccharides
  • Shiga Toxin 2
  • Pectins